Indegene Share Price
Small Cap | Service | NSE: INDGN | BSE: 544172
₹608.10 
7.15 (1.19 %)
Last Updated: 01 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 608.00
High (₹) 610.45
Low (₹) 597.50
Prev. Close (₹) 600.95
Volume 9,990
VWAP (₹) 599.81
ROCE (%) 26.13
Industry P/E 54.51
TTM P/E 37.91
P/B Ratio 9.47
Market Cap (₹) Cr.14,578.65
Dividend Yield (%)--
EPS (₹) 15.07
ROE23.41%
Sales Growth (%) 12.29
Profit Growth (%)26.53
Day Range
610.45610.45
52 Week Range
468.90736.60
Historical Returns
Returns (6M)
7.88 %
Returns (1Y)
6.56 %
Returns (3Y)
6.56 %
Returns (5Y)
6.56 %
Returns (6M)
7.88 %
Returns (1Y)
6.56 %
Returns (3Y)
6.56 %
Returns (5Y)
6.56 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 49.43
MFI 41.92
ATR 26.17
Commodity Channel Index -77.62
ROC125 -1.30
ROC21 -0.51
Williams %R -81.33
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 611.10 | 621.25 | 630.80 | 601.55 | 591.40 | 581.85 | 571.70 |
| Week Ago | 665.09 | 672.17 | 680.69 | 656.57 | 649.49 | 640.97 | 633.89 |
| Month Ago | 608.09 | 612.12 | 617.54 | 602.67 | 598.64 | 593.22 | 589.19 |
EMA & SMA
608.10
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
18
5 Day 609.24
9 Day 636.69
10 Day 642.23
12 Day 639.65
14 Day 636.94
20 Day 626.01
26 Day 619.52
50 Day 623.71
100 Day 648.51
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Dec, 2024 | Manish Gupta | Acquisition | ₹599.1873529411764705882352941 | 17,000 | BSE |
| 23 Dec, 2024 | Sanjay Suresh Parikh | Acquisition | ₹606.5241818181818181818181818 | 16,500 | BSE |
| 23 Dec, 2024 | Rajesh Bhaskaran Nair | Acquisition | ₹598.26388 | 25,000 | BSE |
| 18 Dec, 2024 | Rajesh Bhaskaran Nair | Acquisition | ₹595.80954 | 1,00,000 | BSE |
| 05 Dec, 2024 | Viveksheel A. Ghai | Disposal | ₹627.63705 | 20,000 | BSE |
| 28 Sept, 2024 | Suhas Prabhu | Disposal | ₹672.6903225806451612903225806 | 620 | BSE |
| 28 Sept, 2024 | Suhas Prabhu | Disposal | ₹669.3996152288375860672336979 | 49,380 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 31 Jan, 2025 | BSE India | Pursuant to Regulation 30 and 46(2)(o) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, \r\nthe audio recording of the Q3FY25 earnings call, conducted on January 31,2025 is attached. |
| 30 Jan, 2025 | BSE India | Pursuant to Regulation 30 of SEBILODR Regulation, 2015, we hereby inform you that the Board of Directors of Indegene Limited at its meeting held today that is January 30, 2025 has recommended to the shareholders, the appointment of Deloitte Haskins and SellsDHS , Registration No: 008072S as Statutory Auditors of the company for a term of 5 years from the conclusion of 27th AGM till the conclusion of 32nd AGM of the company.\r\n\r\nThe Board considered the matter that the tenure of the existing Statutory Auditor of the company BSR &Co LLP FRN: 101248W/W-100022 will end at the 27th AGM of the company. |
| 30 Jan, 2025 | NSE India | INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities |
| 30 Jan, 2025 | NSE India | Indegene Limited has informed the Exchange regarding Change in Auditors of the company. |
| 30 Jan, 2025 | BSE India | Pursuant to Regulation 30 of the SEBI LODR Regulation, 2015, the Analyst presentation and fact sheet for the Q3FY25 with respect to financial results for the quarter ended December 31, 2024 are hereby enclosed. |
| 30 Jan, 2025 | NSE India | Indegene Limited has informed the Exchange about Investor Presentation |
| 30 Jan, 2025 | BSE India | We wish to inform you that the company has made a press release dated January 30, 2025, announcing the financial results for the quarter ended December 31, 2024 as approved by the board of Directors at its meeting on January 30, 2025 |
| 30 Jan, 2025 | NSE India | Indegene Limited has informed the Exchange regarding a press release dated January 30, 2025, titled ""Press Release regarding financial results for the quarter ended December 31, 2024 "". |
| 30 Jan, 2025 | BSE India | The unaudited consolidated financial results of the company and its subsidiaries as per INDAS for the quarter ended December 31, 2024 along with the Limited review report of the Auditors thereon.\r\n\r\nThe unaudited standalone financial results of the company as per INDAS for the quarter ended December 31, 2024 along with the limited review report of the Auditors thereon.\r\n\r\nTo Allot shares under ESOP 2020 plan & RSU 2020 plan. |
| 30 Jan, 2025 | NSE India | Indegene Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 28 Jan, 2025 | 30 Jan, 2025 |
| Quarterly Results | -- | 23 Oct, 2024 | 28 Oct, 2024 |
| Quarterly Results | -- | 26 Jul, 2024 | 01 Aug, 2024 |
| Audited Results | -- | 23 May, 2024 | 29 May, 2024 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | May, 2024 |
|---|
About Indegene
Indegene is a Public Limited Listed company incorporated on 16/10/1998 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is U73100KA1998PLC102040 and registration number is 102040. Currently company belongs to the Industry of Services - Others. Company’s Total Operating Revenue is Rs. 1045.60 Cr. and Equity Capital is Rs. 44.40 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1998
Managing Director
-- --
NSE Symbol
INDGN
Indegene Management
| Name | Designation |
|---|---|
| Mr. Manish Gupta | Chairman & CEO |
| Dr. Sanjay Suresh Parikh | Executive Director |
| Dr. Rajesh Bhaskaran Nair | Non Executive Director |
| Mr. Krishnamurthy Venugopala Tenneti | Ind. Non-Executive Director |
| Dr. Ashish Gupta | Ind. Non-Executive Director |
| Mr. Jairaj Manohar Purandare | Ind. Non-Executive Director |
| Mr. Parvin Udhyavara Bhadya Rao | Ind. Non-Executive Director |
| Dr. Georgia Nikolakopoulou Papathomas | Ind. Non-Executive Director |
| Mr. Neeraj Bharadwaj | Non Exe. & Nominee Director |
| Mr. Mark Francis Dzialga | Non Exe. & Nominee Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| CRISIL | ₹40,850.67 | ₹5,452.90  ₹5,433.30(0.36%) | ₹3,665.100 - ₹5,921.100 |
| CDSL | ₹37,150.80 | ₹1,306.90  ₹1,309.70(-0.21%) | ₹811.000 - ₹1,989.800 |
| Inter.Gemmo | ₹25,350.49 | ₹512.70 ₹506.60(1.20%) | ₹454.550 - ₹610.400 |
| Indegene | ₹14,403.99 | ₹609.30 ₹599.70(1.60%) | ₹468.900 - ₹736.600 |
| Quess Corp | ₹9,815.59 | ₹614.95 ₹595.80(3.21%) | ₹460.000 - ₹875.000 |
FAQs on Indegene
What is the share price of Indegene?
The share price of Indegene on 01 Feb, 2025 is ₹ 608.10.
What is 52W high and 52W low share price of Indegene?
The highest and lowest 52W share prices of Indegene are ₹ 736.600 and ₹ 468.900
What is the market cap of Indegene?
The market capitalization of Indegene as of 01 Feb, 2025 is ₹ 14,578.65 Crores
What is the P/E ratio of Indegene?
The current P/E ratio of Indegene as of 01 Feb, 2025 is 54.51
What is the PB ratio of Indegene?
The PB ratio of Indegene as of 01 Feb, 2025 is 9.47
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)